Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conditional Reactivation of Lysozyme Nanosystems via Hydrophobic Ion Pairing.

ACS nanoscience Au·2026
Same author

Towards targeted drugs and next generation of nanomedicines.

Beilstein journal of nanotechnology·2026
Same author

Zwitterionic [Gd-(DOTA)] MRI Probes: Influence of Sulfobetaine Linker Length on Relaxivity.

ACS omega·2026
Same author

Uptake of Nanoparticles as a Model System for Viruses under the Presence of Chloroquine.

ACS nanoscience Au·2026
Same author

Zwitterionic Mn(III)-Tetraphenyl Porphyrins: Water-Soluble MRI Contrast Agents with High Relaxivity.

ChemMedChem·2026
Same author

Peer Review and AI: Your (Human) Opinion Is What Matters.

ACS nano·2026
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2025

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.3K

Developing future nanomedicines.

Neus Feliu1, Wolfgang J Parak2

  • 1Zentrum für Angewandte Nanotechnologie CAN, Fraunhofer- Institut für Angewandte Polymerforschung IAP, Hamburg, Germany.

Science (New York, N.Y.)
|April 25, 2024
PubMed
Summary
This summary is machine-generated.

Quantitative analysis of nanoparticle biodistribution and clearance is key to improving their development. Understanding how nanoparticles spread and are eliminated from the body aids in creating more effective nanoparticle-based therapies.

More Related Videos

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

986
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K

Related Experiment Videos

Last Updated: Jun 27, 2025

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.3K
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

986
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K

Area of Science:

  • Nanotechnology
  • Pharmacokinetics
  • Biomedical Engineering

Background:

  • Nanoparticle development is crucial for advanced drug delivery and diagnostics.
  • Understanding the in vivo behavior of nanoparticles is essential for their clinical translation.
  • Current methods for assessing nanoparticle fate in the body require refinement.

Purpose of the Study:

  • To highlight the importance of quantitative biodistribution and clearance analysis in nanoparticle research.
  • To emphasize how these analyses can accelerate the development of novel nanoparticle formulations.
  • To underscore the impact of pharmacokinetic studies on nanoparticle efficacy and safety.

Main Methods:

  • Review of existing quantitative techniques for biodistribution assessment.
  • Analysis of clearance mechanisms and their impact on nanoparticle retention.
  • Discussion of imaging and analytical methods used in pharmacokinetic studies.

Main Results:

  • Quantitative biodistribution data provides critical insights into nanoparticle targeting and accumulation.
  • Clearance rates significantly influence the therapeutic window and potential toxicity of nanoparticles.
  • Improved analytical methods enable more precise and reliable assessment of nanoparticle fate.

Conclusions:

  • Quantitative analysis of nanoparticle biodistribution and clearance is indispensable for optimizing nanoparticle design.
  • This approach facilitates the development of safer and more effective nanomedicines.
  • Further research into advanced analytical techniques will enhance nanoparticle-based therapeutic strategies.